Home » Cerulean Grabs $24 Million for Nano Drugs
Cerulean Grabs $24 Million for Nano Drugs
Tiny drugs just got a big endorsement. Cambridge, Mass.-based Cerulean Pharmaceuticals has closed a $24 million Series C funding round to fuel development of its nanoparticle drugs, the company announced Monday.
Xconomy
Xconomy
Upcoming Events
-
07May
-
14May
-
30May